Medically reviewed by Dr. Kishan Srikanth Juvva, MD, DM (Pulmonary & Critical Care), Master’s in Interventional Pulmonology (University of Florence), Senior Consultant – Clinical & Interventional Pulmonology and Sleep Medicine, Apollo Hospitals, Financial District, Hyderabad

The short answer: An EBUS report describes what was found in the cells taken from the lymph nodes in your chest. “Reactive” usually means the node is reacting to inflammation or infection, with no cancer seen in the sample. “Granuloma” (or “granulomatous lymphadenitis”) means clusters of immune cells, most often from TB or sarcoidosis in India. “Non-diagnostic” means the sample didn’t give an answer. None of these is the final word on its own: your pulmonologist puts the report together with your CT scan, TB tests and symptoms to decide on treatment, follow-up scans or a repeat biopsy.

You’ve had an EBUS (endobronchial ultrasound) and now you’re holding a report full of words like “reactive lymphoid cells”, “epithelioid granulomas” or “no malignant cells seen”. This article explains what the common phrases mean, how doctors use them, and when a second sample is needed.

A quick reminder: what EBUS samples

EBUS-TBNA uses a thin bronchoscope with an ultrasound probe to find lymph nodes and masses in the middle of the chest (the mediastinum). It then takes cells and small tissue cores through a fine needle. The samples are sent for:

  • cytology or histopathology: a pathologist looks at the cells under a microscope
  • TB tests: CBNAAT (GeneXpert) or Truenat, and TB culture
  • special stains, and tests for cancer type and genes (immunohistochemistry and molecular markers), if cancer is found
  • sometimes, fungal tests or flow cytometry (for lymphoma)

How the procedure is done, how to prepare and what it costs are covered on our EBUS page: EBUS-TBNA in Hyderabad.

What does a “reactive lymph node” mean?

A reactive node is one that has enlarged because it’s doing its job: responding to infection or inflammation somewhere in the chest. On an EBUS report, you might see “reactive lymphoid cells”, “reactive lymphadenitis”, “polymorphous lymphoid population” or “no malignant cells seen”.

In most people, that’s reassuring. Common reasons for reactive nodes include:

  • past or current chest infections, including COVID-19 or pneumonia
  • COPD, asthma or interstitial lung disease
  • exposure to smoke, dust or pollution
  • heart failure (fluid around the lungs)

But “reactive” isn’t always the end of the story. A needle samples only a small part of a node. If the CT scan, PET scan or symptoms still point strongly to something else, such as cancer or TB, your doctor may recommend:

  • a follow-up CT scan in a few months, to check that the node is shrinking or stable
  • a repeat EBUS, sampling more nodes or more passes
  • a different test, such as mediastinoscopy or a CT-guided biopsy

In a 2026 study from a tuberculosis-endemic region of northeast India, 13.5% of patients who had EBUS for enlarged chest nodes were finally diagnosed with reactive lymphadenitis. 36.5% had cancer, 23% had TB and 5.4% had sarcoidosis (Monaldi Archives for Chest Disease). In India, a reactive result is one of several common outcomes, not a rare one.

Granuloma on EBUS: TB or sarcoidosis?

A granuloma is a small, organised cluster of immune cells that forms when the body tries to wall off something it can’t easily clear. Reports may say “epithelioid cell granulomas”, “granulomatous lymphadenitis” or “granulomatous inflammation”. It’s one of the most searched-for report phrases in India.

The two most common causes in India are TB and sarcoidosis, and telling them apart matters because the treatments are completely different.

Clue More suggestive of TB More suggestive of sarcoidosis
Report wording “Necrotising” or “caseating” granulomas; necrosis “Non-necrotising” or “non-caseating” granulomas
Lab tests on the sample CBNAAT/Truenat or TB culture positive; AFB stain positive TB tests negative
Symptoms Fever, night sweats, weight loss, cough Often mild or none; sometimes eye, skin or joint involvement
CT pattern Nodes with low-density (necrotic) centres; lung changes typical of TB Both sides of the chest symmetrically; small nodules along the airways
Blood tests — Sometimes raised ACE or calcium

No single clue settles it. TB tests on lymph-node samples are often negative even when TB is present. In the northeast India study, CBNAAT was positive in only 47.1% of the patients finally diagnosed with TB. Doctors often have to weigh the whole picture. Sometimes they start TB treatment based on strong evidence and watch the response, or repeat sampling to look for TB more closely.

Other, less common causes of granulomas include fungal infections, reactions to some medicines, and occasionally granulomas near a cancer. That’s why the report has to be read alongside everything else.

Never start, stop or switch to TB or steroid treatment based on the report alone. Steroids, the usual treatment for sarcoidosis, can make untreated TB much worse.

“Non-diagnostic”, “inadequate” or “negative”: what next?

These words mean different things:

  • “Inadequate” or “insufficient”: the sample didn’t contain enough of the right cells to judge, for example mostly blood.
  • “Non-diagnostic”: there were cells, but they didn’t show what’s causing the enlarged node.
  • “Negative for malignancy”: no cancer cells were seen in the sample.

A negative or non-diagnostic EBUS doesn’t rule disease out. In a 2024 study of 618 patients, EBUS-TBNA was non-diagnostic in 11.6%. When it was negative, it was a true negative only about a quarter of the time (negative predictive value 27.8%), so most of those patients still needed further tests to reach a diagnosis (Frontiers in Medicine). Results vary widely by centre and by who is having the test. But the lesson holds: if the CT or PET scan looks suspicious and the EBUS is negative, your doctor will usually recommend more.

Typical next steps:

  • Review with the CT or PET scan: do the nodes look cancerous, or more like inflammation?
  • Repeat EBUS: more passes, more nodes, or a different needle size.
  • Other biopsies: EUS through the food pipe, CT-guided biopsy, or surgical mediastinoscopy.
  • Watchful follow-up: if suspicion is low, a repeat CT scan in a few months.

If you’ve been told your EBUS was “normal” but you’re still unsure what that means for you, ask directly: “Is this result enough to rule out cancer and TB in my case, or do we need more tests?”

How long do EBUS results take?

Timings vary by hospital. These are typical:

Test Typical time
Rapid on-site evaluation (ROSE), if available During the procedure, to check the sample is adequate
Cytology or histopathology 2–5 working days
CBNAAT / Truenat (TB and rifampicin resistance) 1–2 days
Special stains and immunohistochemistry (if cancer) A few more days
Molecular and genetic tests for lung cancer (for example EGFR, ALK, PD-L1) 1–2 weeks
TB culture and drug-sensitivity tests Up to 6–8 weeks

You’ll usually be asked to come back for a results visit, where the pulmonologist explains the full report alongside your scans.

When is a repeat biopsy needed?

A repeat EBUS or a different biopsy is usually considered when:

  • the sample was inadequate or non-diagnostic
  • the result doesn’t fit the CT or PET scan, for example “reactive” but the nodes look suspicious
  • cancer was found but more tissue is needed for cancer-type or genetic testing
  • TB is suspected but the tests are negative and the picture is unclear
  • lymphoma is suspected, which often needs larger tissue samples

A repeat biopsy isn’t a failure. It’s a normal step when the first answer isn’t enough to act on safely.

Questions to ask at your results visit

  • What exactly does my report say, and what does it mean for me?
  • Do the results match my CT or PET scan?
  • Is this enough to rule out cancer? And TB?
  • Are any results still pending, such as culture or genetic tests?
  • What’s the next step: treatment, follow-up scan or repeat biopsy?
  • If TB or sarcoidosis, how sure are we, and what’s the plan if treatment doesn’t work?

Getting an EBUS report reviewed in Hyderabad

Dr. Kishan Srikanth Juvva is an interventional pulmonologist in Hyderabad, with a Master’s in Interventional Pulmonology from the University of Florence, Italy. He performs EBUS-TBNA at Apollo Hospitals, Financial District, and reviews EBUS and biopsy reports done elsewhere, alongside the CT or PET scan. His other qualifications:

  • MD from Guntur Medical College
  • DM in Pulmonary & Critical Care Medicine from VMMC & Safdarjung Hospital, New Delhi (All India Rank 2, NEET Super Speciality)
  Apollo Hospitals, Financial District Breathe Well Clinic, Kondapur
Best for EBUS, bronchoscopy, results review with scans Evening consultation and report review
Timings Monday–Saturday, 9:00 AM–5:00 PM Monday–Saturday, 5:00–8:30 PM
Address 1st Floor, Room 3, Apollo Hospitals, Financial District, Nanakramguda 1st Floor, Kadiri’s Apurupa Urban Apartments, Botanical Garden Road, beside Aparna Heights, Kondapur
Book +91 90598 73547 +91 87122 23696

Bring with you: the full EBUS report (cytology, histopathology and any TB test reports), the CT or PET scan images on CD or link, earlier scans for comparison, and a list of your medicines.

 

Frequently asked questions

1. What does a reactive lymph node on EBUS mean?
A reactive lymph node is one that has enlarged in response to infection or inflammation, and no cancer cells were seen in the sample. It’s usually reassuring. But a needle samples only part of a node, so if your CT or PET scan still looks suspicious, your doctor may advise a follow-up scan or repeat biopsy.

2. What is granulomatous lymphadenitis?
Granulomatous lymphadenitis means the lymph node contains granulomas: small clusters of immune cells that form around something the body is trying to contain. In India, the most common causes are TB and sarcoidosis. Fungal infections and some medicines are rarer causes. TB tests, the CT pattern and symptoms help find which one it is.

3. How do doctors tell TB from sarcoidosis on EBUS?
TB is suggested by necrotising (caseating) granulomas, positive CBNAAT, Truenat or TB culture, and fever, weight loss or night sweats. Sarcoidosis is suggested by non-necrotising granulomas, negative TB tests and a typical symmetric CT pattern. TB tests on node samples are often negative, so doctors weigh all the findings together.

4. Does a negative EBUS rule out cancer?
Not always. A negative or non-diagnostic EBUS means no cancer was seen in the sample, but a needle samples only part of a node, and some negative results turn out to be false. If your CT or PET scan looks suspicious, your doctor may recommend a repeat EBUS, another biopsy or a follow-up scan.

5. How long do EBUS biopsy results take?
Basic cytology or histopathology results usually take 2–5 working days. Rapid TB tests (CBNAAT or Truenat) take 1–2 days. Special stains and genetic tests for lung cancer can take one to two weeks, and TB culture up to six to eight weeks. Your doctor will review the results with your scans at a follow-up visit.

6. Why would I need a repeat EBUS?
A repeat EBUS may be needed if the first sample was inadequate or non-diagnostic, if the result doesn’t match the CT or PET scan, if more tissue is needed for cancer-type or genetic testing, or if TB or lymphoma is suspected but not confirmed. It’s a normal step, not a sign the first test went wrong.

 

Medically reviewed by Dr. Kishan Srikanth Juvva, MD, DM (Pulmonary & Critical Care), Senior Consultant, Apollo Hospitals, Financial District, Hyderabad. This article is for general information and doesn’t replace a consultation with your doctor.

 

Sources

  • Muchahary J, Nongpiur VN, Lyngdoh WV, Kalita P, Marbaniang E, Raphael V, Gogoi N, Lohe Y. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration for isolated mediastinal lymphadenopathy in a tuberculosis-endemic region: first study from Northeast India, Monaldi Archives for Chest Disease, early access 23 Mar 2026 (NEIGRIHMS, Meghalaya; 74 patients; malignancy 36.5%, TB 23%, reactive 13.5%, sarcoidosis 5.4%; diagnostic yield 78.6%; CBNAAT positive in 47.1% of TB cases; NPV 62.5%)
  • Liao H, Zhu M, Li R, Wang D, Xiao D, Chen Y, Cheng Z. Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing thoracic lesions: a retrospective cohort study, Frontiers in Medicine 11, May 2024 (618 patients; non-diagnostic 11.6%; NPV 27.8%; sensitivity 91.3%)
  • Luthra K, Singh J. Diagnostic accuracy, indications, and negative predictive value of EBUS-TBNA procedure, Journal of the Association of Chest Physicians 9(2): 53–58, 2021 (NPV 76.5%; accuracy higher under deep sedation or general anaesthesia)